BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31918733)

  • 1. Predictors of historical change in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993-2007.
    Tempalski B; Williams LD; West BS; Cooper HLF; Beane S; Ibragimov U; Friedman SR
    Subst Abuse Treat Prev Policy; 2020 Jan; 15(1):3. PubMed ID: 31918733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change and variability in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993-2007.
    Tempalski B; Cleland CM; Williams LD; Cooper HLF; Friedman SR
    Subst Abuse Treat Prev Policy; 2018 Aug; 13(1):28. PubMed ID: 30092806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends over time in HIV prevalence among people who inject drugs in 89 large US metropolitan statistical areas, 1992-2013.
    Williams LD; Ibragimov U; Tempalski B; Stall R; Satcher Johnson A; Wang G; Cooper HLF; Friedman SR
    Ann Epidemiol; 2020 May; 45():12-23. PubMed ID: 32439148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Injecting Drug Use and Coverage of Interventions to Prevent HIV and Hepatitis C Virus Infection Among People Who Inject Drugs in Canada.
    Jacka B; Larney S; Degenhardt L; Janjua N; Høj S; Krajden M; Grebely J; Bruneau J
    Am J Public Health; 2020 Jan; 110(1):45-50. PubMed ID: 31725310
    [No Abstract]   [Full Text] [Related]  

  • 5. Access to harm reduction programs among persons who inject drugs: findings from a respondent-driven sampling survey in Tehran, Iran.
    Rahnama R; Mohraz M; Mirzazadeh A; Rutherford G; McFarland W; Akbari G; Malekinejad M
    Int J Drug Policy; 2014 Jul; 25(4):717-23. PubMed ID: 24974367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access to and use of health and social services among people who inject drugs in two urban areas of Mozambique, 2014: qualitative results from a formative assessment.
    Dengo-Baloi L; Boothe M; Semá Baltazar C; Sathane I; Langa DC; Condula M; Ricardo H; Inguane C; Teodoro E; Gouveia L; Raymond HF; Horth R
    BMC Public Health; 2020 Jun; 20(1):975. PubMed ID: 32571365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
    Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
    Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.
    Tempalski B; Cooper HL; Friedman SR; Des Jarlais DC; Brady J; Gostnell K
    Int J Drug Policy; 2008 Apr; 19 Suppl 1(Suppl 1):S47-58. PubMed ID: 18295468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates of public support toward federal funding for harm reduction strategies.
    Kulesza M; Teachman BA; Werntz AJ; Gasser ML; Lindgren KP
    Subst Abuse Treat Prev Policy; 2015 Jun; 10():25. PubMed ID: 26122408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceived acceptability of and willingness to use syringe vending machines: results of a cross-sectional survey of out-of-service people who inject drugs in Tbilisi, Georgia.
    Otiashvili D; Kirtadze I; Vardanashvili I; Tabatadze M; Ober AJ
    Harm Reduct J; 2019 Mar; 16(1):21. PubMed ID: 30898120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007.
    Tempalski B; Pouget ER; Cleland CM; Brady JE; Cooper HL; Hall HI; Lansky A; West BS; Friedman SR
    PLoS One; 2013; 8(6):e64789. PubMed ID: 23755143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of the degree of drug treatment coverage for injection drug users in 94 metropolitan areas in the United States of America.
    Friedman SR; Tempalski B; Brady JE; Friedman JJ; Cooper HL; Flom PL; McGrath MM; Gostnell K; Des Jarlais DC
    Int J Drug Policy; 2007 Dec; 18(6):475-85. PubMed ID: 18061873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare Access and Utilization Among Persons Who Inject Drugs in Medicaid Expansion and Nonexpansion States: 22 United States Cities, 2018.
    Lewis R; Baugher AR; Finlayson T; Wejnert C; Sionean C;
    J Infect Dis; 2020 Sep; 222(Suppl 5):S420-S428. PubMed ID: 32877551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racialized risk environments in a large sample of people who inject drugs in the United States.
    Cooper HL; Linton S; Kelley ME; Ross Z; Wolfe ME; Chen YT; Zlotorzynska M; Hunter-Jones J; Friedman SR; Des Jarlais D; Semaan S; Tempalski B; DiNenno E; Broz D; Wejnert C; Paz-Bailey G;
    Int J Drug Policy; 2016 Jan; 27():43-55. PubMed ID: 26342272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing Syringe Exchange Program Access among Persons Who Inject Drugs (PWID) in the District of Columbia.
    Allen ST; Ruiz MS; Jones J
    J Urban Health; 2016 Feb; 93(1):131-40. PubMed ID: 26786782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs.
    Bruggmann P; Grebely J
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S22-6. PubMed ID: 25245939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of high-risk drug use and coverage of opioid substitution treatment and needle and syringe programs in Lithuania in 2015-2016: A multi-method estimation study.
    Thanki D; Mravčík V; Běláčková V; Mačiulytė D; Zábranský T; Širvinskienė A; Subata E; Lorenzo-Ortega R
    J Subst Abuse Treat; 2021 Mar; 122():108229. PubMed ID: 33509418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the number of people who inject drugs and syringe coverage in Australia, 2005-2016.
    Kwon JA; Iversen J; Law M; Dolan K; Wand H; Maher L
    Drug Alcohol Depend; 2019 Apr; 197():108-114. PubMed ID: 30802734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Service utilization and cost of implementing a comprehensive HIV prevention and care program among people who inject drugs in Delhi, India.
    Sebastian MP; Dasgupta A; Saraswati LR; Singh A; Sharma V; Madan I; Tun W; Pulerwitz J; Thior I; Sarna A
    Harm Reduct J; 2017 Jun; 14(1):38. PubMed ID: 28615077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying Which Place Characteristics are Associated with the Odds of Recent HIV Testing in a Large Sample of People Who Inject Drugs in 19 US Metropolitan Areas.
    Tempalski B; Cooper HLF; Kelley ME; Linton SL; Wolfe ME; Chen YT; Ross Z; Des Jarlais DC; Friedman SR; Williams LD; Semaan S; DiNenno E; Wejnert C; Broz D; Paz-Bailey G;
    AIDS Behav; 2019 Feb; 23(2):318-335. PubMed ID: 29971735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.